Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 501665081

ACADS Mouse anti-Human, Clone: OTI1D2, lyophilized, TrueMAB™
SDP

Catalog No. 501665081
Encompass_Preferred
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-166-5081 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-166-5081 Supplier OriGene Supplier No. CF800429
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Reconstitute with PBS (pH 7.3) and recommend to perform another round of desalting process using Product No. 7KMWCO

Introduces a double bond at position 2 in saturated acyl-CoA′s of short chain length, i.e. less than 6 carbon atoms.

Specifications

Antigen ACADS
Applications Immunohistochemistry (Paraffin), Western Blot
Classification Monoclonal
Clone OTI1D2
Conjugate Unconjugated
Formulation PBS with 8% trehalose and no preservative; pH 7.3
Gene ACADS
Gene Accession No. P16219
Gene Alias ACAD3, SCAD
Gene Symbols ACADS
Host Species Mouse
Immunogen Human recombit protein fragment corresponding to amino acids 34-260 of human ACADS produced in E.coli.
Purification Method Affinity Chromatography
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 35
Target Species Human
Content And Storage -20° C, Avoid Freeze/Thaw Cycles
Product Type Antibody
Form Lyophilized
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.